OPTN
Price:
$9.6
Market Cap:
$97.22M
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase IIIb clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. It is also developing OPN-019 that combines liquid EDS device with an antiseptic. The company has a license agreement with Currax Pharmaceuticals LLC for the co...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-10-13
Stock Exchange
NASDAQ
Ticker
OPTN
According to OptiNose, Inc.’s latest financial reports and current stock price. The company's current ROE is 64.39%. This represents a change of 377.20% compared to the average of 13.49% of the last 4 quarters.
The mean historical ROE of OptiNose, Inc. over the last ten years is -163.04%. The current 64.39% ROE has changed -139.49% with respect to the historical average. Over the past ten years (40 quarters), OPTN's ROE was at its highest in in the March 2021 quarter at 156.31%. The ROE was at its lowest in in the December 2020 quarter at -351.56%.
Average
-163.04%
Median
4.66%
Minimum
-1448.59%
Maximum
375.02%
Discovering the peaks and valleys of OptiNose, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 718.84%
Maximum Annual ROE = 375.02%
Minimum Annual Increase = -664.90%
Minimum Annual ROE = -1448.59%
| Year | ROE | Change |
|---|---|---|
| 2024 | 53.37% | 30.27% |
| 2023 | 40.97% | -69.00% |
| 2022 | 132.16% | -64.76% |
| 2021 | 375.02% | -125.89% |
| 2020 | -1448.59% | 718.84% |
| 2019 | -176.91% | 96.73% |
| 2018 | -89.92% | 184.09% |
| 2017 | -31.65% | -94.63% |
| 2016 | -589.19% | -664.90% |
The current ROE of OptiNose, Inc. (OPTN) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
75.50%
5-year avg
-169.41%
10-year avg
-163.04%
OptiNose, Inc.’s ROE is greater than Zomedica Corp. (-51.86%), greater than Five Star Senior Living Inc. (-15.17%), less than Upexi, Inc. (224.22%), greater than Societal CDMO, Inc. (-22.40%), greater than Jounce Therapeutics, Inc. (-25.03%), greater than Procaps Group S.A. (-221.90%), greater than Miromatrix Medical Inc. (-74.80%), greater than Asensus Surgical, Inc. (-117.89%), greater than Aadi Bioscience, Inc. (-8.09%), greater than Zynerba Pharmaceuticals, Inc. (-59.45%),
| Company | ROE | Market cap |
|---|---|---|
| -51.86% | $95.35M | |
| -15.17% | $98.39M | |
| 224.22% | $162.08M | |
| -22.40% | $116.13M | |
| -25.03% | $98.95M | |
| -221.90% | $113.95M | |
| -74.80% | $92.95M | |
| -117.89% | $94.92M | |
| -8.09% | $94.89M | |
| -59.45% | $70.12M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OptiNose, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like OptiNose, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is OptiNose, Inc.'s ROE?
How is the ROE calculated for OptiNose, Inc. (OPTN)?
What is the highest ROE for OptiNose, Inc. (OPTN)?
What is the 3-year average ROE for OptiNose, Inc. (OPTN)?
What is the 5-year average ROE for OptiNose, Inc. (OPTN)?
How does the current ROE for OptiNose, Inc. (OPTN) compare to its historical average?